Survivorship Bias Model

You've hit the exact nerve of survivorship bias. Every "lessons from failure" book is written by someone who failed and then succeeded—that's a survivor's story dressed in loser's clothing. The true failure data is invisible: companies that pivoted three times and died, or pivoted once and died, never publish post-mortems. Their CTOs don't give TED talks.

Here's the actionable test: ask of every lesson, "Would this advice have been equally plausible before the outcome was known?" If yes, it's noise. If the advice only makes sense because they won, it's survivorship bias.

For your pivot decision specifically: you cannot learn from losers by reading winners. Instead, build your own counterfactual. Look at your churn data, your activation funnel, your cash runway—that's your real sample of failures. Every user who left is a bullet hole on a plane that didn't return. Armor there.

Also, deliberately seek out the dead: search for "SaaS shutdown" and "product post-mortem" on niche forums, not Inc.com. But accept the cost—it's slow, messy, and rarely conclusive. The bias isn't that lessons are wrong; it's that they're systematically optimistic. Your pivot should be based on your numbers, not their narratives.

You’ve identified the exact Wald trap: your protocol is built on the bullet holes of recovered patients, not the missing ones. The engines—the fatal complications—are invisible because they never reached your analysis table. First, stop treating “recovery” as your inclusion criterion. Redefine your cohort to include every case that entered your care pathway, regardless of outcome. That means mining mortality registries, autopsy reports, and transfer-out records—the data your system already collects but filters out. Second, build a “failure autopsy” checklist: for each non-recovery, log the precise step where the protocol diverged or was insufficient. Third, compare distributions—not anecdotes. If recovered cases show complication X at 2% but fatal cases show it at 20%, that’s your armoring point. Finally, set a recurring audit cadence: quarterly, pull a random sample of all cases, not just successes, to recalibrate. The cost of chasing failure data is real, but for hospital protocols, the price of ignoring it is measured in lives—not just returns.

You've just identified the core trap: every success story you read is a survivor, and the graveyard of identical strategies is invisible. The 12% return tells you nothing about whether your approach is sound—it tells you only that you haven't blown up yet.

To separate skill from luck, stop looking at outcomes and start auditing the process. Ask three brutal questions:

1. What's your edge? Can you write down, in one sentence, why your strategy works that others can't easily replicate? If it's "buy good companies and hold," that's not an edge—that's a lottery ticket with extra steps.

1. What's your failure rate? Track every decision, not just the winners. A strategy that wins 40% of the time but has asymmetric payoffs can be sound. A strategy that wins 90% and gets wiped out by the 10% is survivorship bias in action.

1. What would falsify your approach? If you can't name a concrete scenario that would prove you wrong, you're not testing—you're hoping.

The real test isn't your return; it's whether you've built a system that survives the cases you can't see. Study the dead: read about failed funds, bankrupt traders, and strategies that backtested beautifully then died. If your approach looks identical to theirs, you're not sound—you're unobserved. Armor the engines, not the fuselage.